
Global Coronary Artery Bypass Grafting Market 2022-2026
Description
Global Coronary Artery Bypass Grafting Market 2022-2026
Technavio has been monitoring the coronary artery bypass grafting market and it is poised to grow by $ 34.01 mn during 2022-2026, progressing at a CAGR of 5% during the forecast period. Our report on the coronary artery bypass grafting market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of CVDs, growing medical tourism in developing economies, and a growing number of cardiovascular surgeries.
The coronary artery bypass grafting market analysis includes product type segment and geographic landscape.
Technavio's coronary artery bypass grafting market is segmented as below:
By Product Type
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the coronary artery bypass grafting market covers the following areas:
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Companies Mentioned
Abbott Laboratories, Aesculap Inc., AtriCure Inc., Aruga Technologies, Bentley InnoMed GmbH, BIOTRONIK SE and Co KG, Boston Scientific Corp., Artivion Inc., Genesee BioMedical Inc., Getinge AB, Johnson and Johnson Inc., KARL STORZ SE and Co. KG, KLS Martin Group, Medtronic Plc, Saphena Medical Inc., Scanlan International Inc., Stryker Corp., Terumo Corp., VasoPrep Surgical, Cook Medical LLC, Teleflex Inc.
Technavio has been monitoring the coronary artery bypass grafting market and it is poised to grow by $ 34.01 mn during 2022-2026, progressing at a CAGR of 5% during the forecast period. Our report on the coronary artery bypass grafting market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of CVDs, growing medical tourism in developing economies, and a growing number of cardiovascular surgeries.
The coronary artery bypass grafting market analysis includes product type segment and geographic landscape.
Technavio's coronary artery bypass grafting market is segmented as below:
By Product Type
- On-Pump
- Off-Pump
- Minimally Invasive Surgery
- North America
- Europe
- APAC
- Rest of World (ROW)
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the coronary artery bypass grafting market covers the following areas:
- Coronary artery bypass grafting market sizing
- Coronary artery bypass grafting market forecast
- Coronary artery bypass grafting market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Companies Mentioned
Abbott Laboratories, Aesculap Inc., AtriCure Inc., Aruga Technologies, Bentley InnoMed GmbH, BIOTRONIK SE and Co KG, Boston Scientific Corp., Artivion Inc., Genesee BioMedical Inc., Getinge AB, Johnson and Johnson Inc., KARL STORZ SE and Co. KG, KLS Martin Group, Medtronic Plc, Saphena Medical Inc., Scanlan International Inc., Stryker Corp., Terumo Corp., VasoPrep Surgical, Cook Medical LLC, Teleflex Inc.
Table of Contents
120 Pages
- Market overview
- Market ecosystem
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021-2026
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Product Type
- On-pump - Market size and forecast 2021-2026
- Off-pump - Market size and forecast 2021-2026
- Minimally invasive surgery - Market size and forecast 2021-2026
- Market opportunity by Product Type
- Customer landscape overview
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- APAC - Market size and forecast 2021-2026
- Rest of World (ROW) - Market size and forecast 2021- 2026
- US - Market size and forecast 2021-2026
- China - Market size and forecast 2021-2026
- Russia - Market size and forecast 2021-2026
- Canada - Market size and forecast 2021-2026
- India - Market size and forecast 2021-2026
- Market opportunity by geography
- Market drivers
- Market challenges
- Impact of drivers and challenges
- Market trends
- Overview
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Boston Scientific Corp.
- Genesee BioMedical Inc.
- Getinge AB
- Johnson and Johnson Inc.
- KARL STORZ SE and Co. KG
- Medtronic Plc
- Scanlan International Inc.
- Stryker Corp.
- Terumo Corp.
- Scope of the report
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.